Maryland Heights, MO, May 17, 2017 --(PR.com)-- Opioids are a major class of analgesics and very effective for treating and managing pain. The class includes substances such as codeine, fentanyl, morphine, methadone, and oxycodone. However, constipation is a major gastrointestinal side effect caused due to long term opioid treatment in chronic pain patients. Constipation caused due to opioid is severe and is a major barrier to achieve satisfactory pain management in cancerous and noncancerous patients. Constipation, also called as opioid-induced -tramadol / hydrocodone / oxycodone / codeine – constipation, or opioid-induced constipation (OIC), which is a symptom in many patients taking these medications. To overcome this barrier, additional medicines are to be prescribed along with opioid to treat opioid induced constipation. Increasing number of chronic pain patients, growing acceptance of opioid to treat pain, and launch of new drugs to treat opioid induced constipation are major factors expected to drive the global opioid induced constipation drugs market during the forecast period.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.